GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
GoodRx operates a price comparison platform for prescription drugs which, in many cases, offers consumers access to lower prices for their medications through discount codes and coupons.
- GoodRx operates a price comparison platform for prescription drugs which, in many cases, offers consumers access to lower prices for their medications through discount codes and coupons.
- or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
- If you suffered a loss in GoodRx you have until June 21, 2024, to request that the Court appoint you as lead plaintiff.
- Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.